Thomas Kisby

Thomas Kisby


Personal profile


My group aims tp exploit the properties of nanomaterials/advanced materials and their interactions with cells and tissues for the development of safe and effective medicines, using advanced clinically-relevant disease models. Our mission is to further the progress of nanomedicine toward clinical translation, particularly in disease areas failed by conventional drugs and therapies such as neurooncology.

More information on the team and our work can be found here:


Tom obtained a BSc in Medical Sciences at the University of Leeds in 2015. During his studies, he conducted an industrial placement year at MedImmune (Astra Zeneca) investigating novel bio-therapies for inflammatory liver disease and fibrosis. 

Tom joined the Nanomedicine Lab as a PhD student funded by the EPSRC & MRC Centre for Doctoral Training in Regenerative Medicine at the University of Manchester. His PhD project investigated in vivo cell reprogramming as a strategy to enhance tissue repair and regeneration using adenoviral vectors for gene tranfer. In December 2019 he was recruited as a postdoctoral researcher funded by an EPSRC International Centre-to-Centre of Excellence grant between the Universities of Manchester and Harvard.

He was appointed as Senior Researcher and Team Leader of the NanoTherapeutics Team in June 2021 investigating the application of 2D and other nanomaterials for advanced cancer therapies and has obtained funding from the MRC Confidence in Concept scheme, the NIHR BRC and the Rosetrees Trust. 


MSc Nanomedicine by Research

CDT NowNano

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Doctor of Medicine, Regenerative medicine

Award Date: 16 Dec 2019

Bachelor of Science, Medical Sciences

Award Date: 1 Jul 2015

Areas of expertise

  • RM Therapeutics. Pharmacology
  • Nanomedicine
  • Neuro-oncology
  • Preclinical models

Research Beacons, Institutes and Platforms

  • Advanced materials
  • Cancer
  • Manchester Cancer Research Centre
  • National Graphene Institute
  • Christabel Pankhurst Institute


  • Nanotechnology
  • Nanomedicine
  • Cancer
  • Neuro-oncology
  • Immunotherapy
  • Graphene
  • 2D Materials
  • Immunology
  • Stem Cell Biology
  • Reprogramming
  • Immunomodulation
  • Vaccination


Dive into the research topics where Thomas Kisby is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles